Peripheral giant cell granuloma and peripheral ossifying fibroma: case report of an uncommon presentation
JORDI - Journal of Oral Diagnosis · 05.03.2026 · 11
DOI: 10.5327/2525-5711.418 ↗Kurz gefasst
Fallbericht in der Zeitschrift JORDI - Journal of Oral Diagnosis, online erschienen am 05.03.2026. Verfasst von Isabella Monteiro de Moraes und 2 weiteren Autor:innen. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Lesions exhibiting characteristics of different pathologies within the same lesion, known as hybrid lesions, have been reported in the literature. The aim of this article is to report a case of a rare hybrid lesion of Peripheral giant cell granuloma (PGCG) associated with Peripheral ossifying fibroma (POF) and to discuss its clinical, imaging, and histopathological characteristics. We report the case of 49-year-old man with a lesion that presented clinical, histological and radiological characteristics of PGCG and POF. In conclusion, hybrid lesions involving PGCG and POF are rare and, although they share etiological factors, they may represent variations in the biological response of the affected tissues.
Zitieren
APA
Moraes, I. M. D., Silva, Y. M. D., & Pontes, F. S. C. (2026). Peripheral giant cell granuloma and peripheral ossifying fibroma: case report of an uncommon presentation. JORDI - Journal of Oral Diagnosis, 11. https://doi.org/10.5327/2525-5711.418
Vancouver
Moraes IMD, Silva YMD, Pontes FSC. Peripheral giant cell granuloma and peripheral ossifying fibroma: case report of an uncommon presentation. JORDI - Journal of Oral Diagnosis. 2026;11. doi:10.5327/2525-5711.418
BibTeX
@article{Moraes2026,
author = {Moraes, Isabella Monteiro de and Silva, Yngrid Monteiro da and Pontes, Flávia Sirotheau Corrêa},
title = {Peripheral giant cell granuloma and peripheral ossifying fibroma: case report of an uncommon presentation},
journal = {JORDI - Journal of Oral Diagnosis},
year = {2026},
volume = {11},
doi = {10.5327/2525-5711.418}
}
EUVIMED